Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection
US9845322B2 · kind B2 · utility
3Cited by
1References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2016 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | May 3, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having the general formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.